PH31437A - Tontophoretic delivery of an antimigrane drug. - Google Patents

Tontophoretic delivery of an antimigrane drug.

Info

Publication number
PH31437A
PH31437A PH48643A PH48643A PH31437A PH 31437 A PH31437 A PH 31437A PH 48643 A PH48643 A PH 48643A PH 48643 A PH48643 A PH 48643A PH 31437 A PH31437 A PH 31437A
Authority
PH
Philippines
Prior art keywords
formula
6alkyl
hydrogen
pct
bivalent
Prior art date
Application number
PH48643A
Other languages
English (en)
Inventor
Masens Jean Louis
Reet Van Gustaaf
Beukelaar De Frank Maria Josef
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of PH31437A publication Critical patent/PH31437A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Electrotherapy Devices (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
PH48643A 1993-08-27 1994-07-15 Tontophoretic delivery of an antimigrane drug. PH31437A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP93202523 1993-08-27

Publications (1)

Publication Number Publication Date
PH31437A true PH31437A (en) 1998-11-03

Family

ID=8214068

Family Applications (1)

Application Number Title Priority Date Filing Date
PH48643A PH31437A (en) 1993-08-27 1994-07-15 Tontophoretic delivery of an antimigrane drug.

Country Status (28)

Country Link
US (1) US5674871A (pl)
EP (1) EP0719138B1 (pl)
JP (1) JP2921987B2 (pl)
KR (1) KR100187632B1 (pl)
CN (1) CN1096857C (pl)
AT (1) ATE176591T1 (pl)
AU (1) AU687876B2 (pl)
BR (1) BR9407522A (pl)
CA (1) CA2168449A1 (pl)
CZ (1) CZ290473B6 (pl)
DE (1) DE69416522T2 (pl)
DK (1) DK0719138T3 (pl)
ES (1) ES2129668T3 (pl)
FI (1) FI960887A0 (pl)
GR (1) GR3029920T3 (pl)
HR (1) HRP940481A2 (pl)
HU (1) HUT75062A (pl)
IL (1) IL110784A (pl)
MY (1) MY111022A (pl)
NO (1) NO317628B1 (pl)
NZ (1) NZ273304A (pl)
PH (1) PH31437A (pl)
PL (1) PL176290B1 (pl)
RU (1) RU2166315C2 (pl)
SG (1) SG50469A1 (pl)
SI (1) SI9400333B (pl)
WO (1) WO1995005815A1 (pl)
ZA (1) ZA946533B (pl)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5853383A (en) * 1995-05-03 1998-12-29 Alza Corporation Preparation for formulations for electrotransport drug delivery
US7137975B2 (en) * 2001-02-13 2006-11-21 Aciont, Inc. Method for increasing the battery life of an alternating current iontophoresis device using a barrier-modifying agent
CA2443326A1 (en) * 2001-04-04 2002-10-17 Alza Corporation Transdermal electrotransport delivery device including an antimicrobial compatible reservoir composition
WO2002089803A1 (fr) * 2001-05-07 2002-11-14 Sankyo Company, Limited Composition d'ionophorese
JP4394444B2 (ja) * 2001-10-24 2010-01-06 パワー ペーパー リミティド 活性物質の制御された皮膚内デリバリーのためのデバイス及び方法
ITMI20021200A1 (it) * 2002-06-03 2003-12-03 Gafitex S R L Tessuto atto ad esplicare un effetto barriera contro campi magnetici ed elettromagnetici e/o effetti di metalloterapia
US8016811B2 (en) * 2003-10-24 2011-09-13 Altea Therapeutics Corporation Method for transdermal delivery of permeant substances
US20050220439A1 (en) * 2004-03-19 2005-10-06 Carton Owen A Interactive multimedia system and method
WO2007009462A2 (en) * 2005-07-15 2007-01-25 Region Hovedstaden V/Glostrup Hospital Treatment of migraine and headaches
GB2430364A (en) * 2005-09-22 2007-03-28 Carl Ernest Alexander Soft agar bolus for oral drug delivery
WO2007120747A2 (en) * 2006-04-13 2007-10-25 Nupathe Inc. Transdermal methods and systems for the delivery of anti-migraine compounds
RU2352359C1 (ru) * 2007-10-24 2009-04-20 Общество с ограниченнной ответственностью "НПО Текстильпрогресс Инженерной Академии " (ООО "НПО Текстильпрогресс ИА") Способ создания композиции для доставки лекарственного препарата в полости организма при заболеваниях

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4028125A1 (de) * 1990-01-17 1991-07-18 Klimke Markus Applikationsvorrichtung fuer die geregelte dosierung verschiedener pharmakons mittels elektrischem strom zum perkutanen transport zur lokalen und systemischen therapie
JP3740549B2 (ja) * 1990-03-30 2006-02-01 アルザ・コーポレーション イオン侵透療法による薬剤投与の装置と方法
SI9300097B (en) * 1992-02-27 2001-12-31 Janssen Pharmaceutica Nv (benzodioxan, benzofuran or benzopyran) alkylamino) alkyl substituted guanidines

Also Published As

Publication number Publication date
CN1129905A (zh) 1996-08-28
DE69416522D1 (de) 1999-03-25
DK0719138T3 (da) 1999-09-20
CZ290473B6 (cs) 2002-07-17
SG50469A1 (en) 1998-07-20
FI960887A7 (fi) 1996-02-26
ZA946533B (en) 1996-02-26
GR3029920T3 (en) 1999-07-30
US5674871A (en) 1997-10-07
JP2921987B2 (ja) 1999-07-19
BR9407522A (pt) 1997-01-07
WO1995005815A1 (en) 1995-03-02
AU687876B2 (en) 1998-03-05
SI9400333B (sl) 2002-02-28
PL313255A1 (en) 1996-06-24
ATE176591T1 (de) 1999-02-15
SI9400333A (en) 1995-04-30
NO960769D0 (no) 1996-02-26
IL110784A (en) 1999-05-09
DE69416522T2 (de) 1999-09-23
NO960769L (no) 1996-04-23
CA2168449A1 (en) 1995-03-02
JPH09501180A (ja) 1997-02-04
IL110784A0 (en) 1994-11-11
FI960887A0 (fi) 1996-02-26
ES2129668T3 (es) 1999-06-16
RU2166315C2 (ru) 2001-05-10
HU9600471D0 (en) 1996-04-29
EP0719138B1 (en) 1999-02-10
CZ57096A3 (en) 1996-08-14
KR100187632B1 (ko) 1999-06-01
MY111022A (en) 1999-07-31
AU7654294A (en) 1995-03-21
NZ273304A (en) 1997-02-24
CN1096857C (zh) 2002-12-25
HUT75062A (en) 1997-03-28
EP0719138A1 (en) 1996-07-03
PL176290B1 (pl) 1999-05-31
HRP940481A2 (en) 1997-08-31
NO317628B1 (no) 2004-11-29

Similar Documents

Publication Publication Date Title
IL110784A0 (en) Iontophoretic drug delivery device
NO960648D0 (no) Vasokonstriktive substituerte aryloksyalkyldiaminer
IL124461A (en) Angiogenesis inhibiting 3-(1,2,4-thiadiazol-5-yl)piperazine pyridazine derivatives their preparation and pharmaceutical compositions containing them
MY117852A (en) Alkylaminobenzothiazole and- benzoxazole derivatives
FI943019A0 (fi) Terapeuttisia aineita
IL107654A0 (en) Use of dimethylbenzofurans and dimethylbenzopyrans as 5-ht3 antagonists certain such novel compounds their preparation and pharmaceutical compositions containing them
DE69616825D1 (en) Triazolone als apolipoprotein-b synthese ihibitoren
MY120046A (en) Angiogenesis inhibiting thiadiazolyl pyridazine derivatives.
CA2374902A1 (en) Aminoalkyl substituted benzopyran derivatives for treating impaired fundic relaxation
NZ512891A (en) S-oxide lipid lowering compounds
AU4304596A (en) A process for the preparation of substituted 4-ethyl-piperidines and an intermediate for the preparation of same
IL110688A0 (en) Substituted dihydropyranopyridines, their preparation and pharmaceutical compositions containing them
BR0014447A (pt) Derivados de piperidina como inibidores da reabsorção
DE69508600D1 (de) Phenyl-oxo-alkyl-(4-piperidinyl) benzoatderivate